Skin diseases affect over 4.69 billion people globally, making them one of the top 10 causes of disability. From eczema and psoriasis to rare genetic conditions, skin diseases have devastating impacts on individuals’ health, mental well-being, and livelihoods.
The World Health Assembly (WHA) will meet in May 2025 to adopt a groundbreaking resolution to prioritize skin health as a global health issue.
Oncolytic therapy, introduced a decade ago, is gaining momentum as a promising treatment for melanoma. Advanced practice providers play a key role in implementing therapies like intralesional injections and require education, skill development, and credentialing support as they adopt oncolytic virotherapy. This APSHO-endorsed curriculum offers didactic content, instructional videos, and future hands-on training opportunities to support the expanded use of oncolytic therapies in clinical practice.
The Integrita team brings a scalable, proven approach to healthcare advocacy. It’s about cutting through the clutter to get credible education and resources to the people who need them. It’s about building an engaged and informed community for underserved conditions through innovative methods. To learn more, see our Therapeutic Areas pages for our experience in scalable healthcare provider and patient advocacy initiatives. Harness the power of Integrita to fuel advocacy and make a difference today.